OncoTherapy Science, Inc.
4564.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -¥815 | -¥1,288 | -¥1,116 | -¥2,570 |
| Dep. & Amort. | ¥0 | ¥0 | ¥0 | ¥17 |
| Deferred Tax | ¥0 | ¥0 | ¥0 | ¥545 |
| Stock-Based Comp. | ¥0 | ¥8 | ¥31 | ¥39 |
| Change in WC | -¥75 | -¥90 | ¥340 | -¥61 |
| Other Non-Cash | ¥75 | ¥143 | -¥50 | -¥43 |
| Operating Cash Flow | -¥815 | -¥1,228 | -¥795 | -¥2,073 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -¥0 | -¥3 | -¥5 | -¥457 |
| Net Acquisitions | ¥0 | ¥0 | ¥0 | ¥0 |
| Inv. Purchases | ¥0 | ¥0 | ¥0 | ¥0 |
| Inv. Sales/Matur. | ¥0 | ¥0 | ¥0 | ¥0 |
| Other Inv. Act. | ¥0 | -¥31 | -¥15 | -¥11 |
| Investing Cash Flow | -¥0 | -¥33 | -¥20 | -¥468 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -¥56 | -¥5 | ¥0 | ¥0 |
| Stock Issued | ¥1,175 | ¥683 | ¥0 | ¥1,467 |
| Stock Repurch. | -¥1 | ¥0 | ¥0 | ¥0 |
| Dividends Paid | ¥0 | ¥0 | ¥0 | ¥0 |
| Other Fin. Act. | ¥6 | -¥0 | ¥96 | ¥12 |
| Financing Cash Flow | ¥1,122 | ¥671 | ¥96 | ¥1,479 |
| Forex Effect | ¥0 | ¥0 | -¥0 | -¥0 |
| Net Chg. in Cash | ¥306 | -¥590 | -¥719 | -¥1,062 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | ¥528 | ¥1,118 | ¥1,837 | ¥2,899 |
| End Cash | ¥834 | ¥528 | ¥1,118 | ¥1,837 |
| Free Cash Flow | -¥815 | -¥1,231 | -¥800 | -¥2,530 |